☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Abs
Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop Abs for COVID-19
April 10, 2020
Amgen Signs a Partnership with Adaptive Biotechnologies to Develop Abs for COVID-19
April 10, 2020
AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for Neurological Disorders
February 28, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.